Key result
Antiplatelet therapy was unrecorded for 27% of patients in the analyzed database, highlighting a fundamental limitation in the previously published study.
Key points are not available for this paper at this time.
Design
Editorial
Answers are grounded in this paper and cite their sources.
This letter highlights fundamental flaws regarding missing antiplatelet therapy documentation in a large database study.
To the Editor We read with interest the recently published study by Olier et al .1 Although the cohort of patients studied is impressively large, the study appears to be fundamentally flawed. First, antiplatelet therapy was not recorded for 27% …
No takes yet. Share an insight, caveat, or question.
Merinopoulos et al. (2019) studied this question. Antiplatelet therapy was unrecorded for 27% of patients in the analyzed database, highlighting a fundamental limitation in the previously published study.
Synapse has enriched 10 related papers. Consider them for comparative context: